IL-28B/IFN-lambda 3 Products

HAF007). A specific band was detected for IL-28B/IFN-lambda 3 at approximately 19 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1." class="big_lightbox" target="_blank">

1789-ML) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepatocellular carcinoma cell line in a dose-dependent manner (orange line), as measured by crystal violet staining. Inhibition of EMCV activity elicited by Recombinant Mouse IL-28B/ IFN-lambda 3 (400 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Mouse IL-28B/IFN-lambda 3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1789). The ND₅₀ is typically 2-10 µg/mL." class="big_lightbox" target="_blank">

1789-ML) reduces the Encephalo-myocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepatocellular carcinoma cell line in a dose-dependent manner (orange line). Inhibition of EMCV activity elicited by Recombinant Mouse IL-28B/IFN-lambda 3 (400 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Mouse IL-28B/IFN-lambda 3 Monoclonal Antibody (Cata-log # MAB1789). The ND₅₀ is typically 1.5-6.0 µg/mL." class="big_lightbox" target="_blank">